Despite the rescheduling of medicinal cannabis, very few prescriptions have been issued. One of the many reasons for this is because of the gaps in the evidence base (Parliament, UK)
Bibliography: All Publications
New psychoactive substances in Australia: Who uses them, how prevalent are they, and where are they sourced?
In this article, NDARC’s Dr Rachel Sutherland provides an in-depth overview of new psychoactive substances (NPS) in Australia that covers what they are, who uses them and which specific NPS are being consumed (NDARC)
Drug-related infectious diseases in Europe: update from the EMCDDA expert network
This report presents an overview of infectious diseases among people who inject drugs in Europe, both in the community and in prison settings, covering disease surveillance, outbreak investigations, and prevention and control, for the period up to the end of February 2019 (EMCDDA)
Breaking the embargo: a proposal to break UK public health medicinal cannabis impasse (PDF)
Commissioning national clinical assessments of cannabis-based medicinal products in the management of chronic disease (Centre for Medicinal Cannabis)
World Drug Report 2019
Presented in five separate parts that divide the wealth of information and analysis contained in the report into individual reader-friendly booklets in which drugs are grouped by their psychopharmacological effect for the first time in the report’s history (UNODC)
Classification of Drugs: when science was left behind,
The first-ever comprehensive report providing a political reading of the current evaluation and classification, or “scheduling” of drugs according to their harms (The Global Commission on Drug Policy)
Developments in the European cannabis market
This paper provides an overview of established and emerging cannabis products in Europe. For each type of product, major issues in its production, distribution, use and effects on health are detailed. In doing so, the paper seeks to inform a discussion of the new challenges that may emerge in the monitoring of these products and the consequences of their use (EMCDDA)
Hard Edges
The central aim of this study was to establish a statistical profile of the extent and nature of severe and multiple disadvantage (SMD) in Scotland
Report into homelessness and drug misuse published
Safe housing key to tackling homeless drug misuse, says ACMD report
The International Narcotics Control Board on cannabis: A critique of the report for 2018
As can be seen over the past 45 years or so, the potency of the Report has arguably shifted away from the public and more towards influencing opinion within the UN’s central policy-making body on the issue of drugs, the Commission on Narcotic Drugs (IDPC)
Cannabis-based products for medicinal use
In development [GID-NG10124] Expected publication date: 21 October 2019 (NICE)
National Wastewater Drug Monitoring Program
The Australian Criminal Intelligence Commission has commissioned the University of Queensland, and through it the University of South Australia, to undertake the data collection and analysis that underpins the report. This is the seventh in a series of nine public reports
General Report of Activities 2018 – Key achievements and governance: a year in review
The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme (EMCDDA)
Criminal Justice Project: Class A drug tests in Merseyside Police custody
This report presents data on drug tests carried out across Merseyside’s custody suites between April 2016 and March 2019, with a particular focus given to positive tests in 2018/19 (PHI)
ACMD report: ageing cohort of drug users
Report from the ACMD providing advice to the government on the changing age profile of people accessing drug treatment and the challenges faced by this cohort in the UK
ACMD: avoid Friday prison release to prevent drug relapse and deaths
Prison services could reduce drug-related harms by avoiding releasing vulnerable prisoners on a Friday, the ACMD has today advised the Home Secretary
ACMD report: Custody-community transitions
Report from the Advisory Council on the Misuse of Drugs (ACMD) on how to reduce drug-related harms that occur when people move between custody and the community
European Drug Report 2019: Trends and Developments
he Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug Report package – Download (EMCDDA)
Drugs in syringes from six European cities: results from the ESCAPE project 2017
In this pilot study, chemical analysis of the contents of used syringes collected from exchange sites reveals the drugs and drug combinations injected in the six participating European cities (EMCDDA)
Drug-Related Hospital Statistics Scotland 2017/18
This report describes the number of drug-related hospital stays, the number and characteristics of patients admitted to hospital, the substances involved and the geographical variations within Scotland (ISD)
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 68
- Next Page »
